Sep 02 Paralysis cases could help identify Zika spread, researchers say By Andrew Joseph, STAT Health officials are now finding that reported cases of Zika track closely with the onset of a temporary paralysis called Guillain-Barré syndrome. Continue reading
Sep 02 Clinton offers plan to prevent 'excessive' drug price hikes By Catherine Lucey, Associated Press Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs. Continue reading
Sep 01 Mylan's generic EpiPen — a price break or marketing maneuver? By Julie Appleby, Kaiser Health News Following weeks of criticism, Mylan said Monday it will offer a generic version of its life-saving allergy treatment, the EpiPen. But what does this development mean for consumers and the marketplace?… Continue reading
Aug 31 New Alzheimer's drug clears abnormal protein clogs in small, promising trial By Karen Weintraub, Scientific American Aducanumab, a new drug that some researchers are calling the most promising yet in the fight against Alzheimer’s, suggests it is possible to clear the brain of the amyloid protein, a characteristic of the disease. Continue reading
Aug 31 Baltimore unveils its plan to cut health disparities by 50 percent in a decade By Jay Hancock, Kaiser Health News Violence last year following the death of Freddie Gray, a black man who died after being injured in police custody, exposed Baltimore’s health divide as well as its criminal justice differences, officials said. Gray’s family had won a settlement for… Continue reading
Aug 30 82 cases of Zika emerge from Singapore's local outbreak in less than a week By Eugene Mason Since announcing the first locally transmitted case on Saturday, health officials have uncovered dozens of Zika cases in Singapore without links to travel. Continue reading
Aug 30 Zika stays in the family, mother mosquitoes pass virus to eggs By Nsikan Akpan The inheritance of Zika virus may guarantee its long-term survival in mosquito (and human) populations. Continue reading
Aug 30 Has overmedicating seniors become 'America's other drug problem'? By Anna Gorman, Kaiser Health News An increasing number of elderly patients nationwide are on multiple medications to treat chronic diseases, raising their chances of dangerous drug interactions and serious side effects. Often the drugs are prescribed by different specialists who don’t communicate with each other. Continue reading
Aug 29 Watch 7:41 Did outcry on social media lead to Mylan's generic EpiPen? By PBS News Hour After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New… Continue watching
Aug 29 EpiPen drugmaker announces generic version to cost half the price By News Desk Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two. Continue reading